Mount Sinai, LabCorp, and Philips announced they are collaborating to establish the Mount Sinai Digital and Artificial Intelligence (AI)-Enabled Pathology Center of Excellence. The new center will feature the Philips IntelliSite Pathology Solution, the first digital pathology system FDA approved for primary diagnostic use, which will help the organizations enhance the quality and lower the costs of patient care.Role of LabCorpLabCorp will lead the integration of Philips’ system at Mount Sinai,
Read More
Mount Sinai Health System | Healthcare Delivery Services for Patients | News, Analysis - HIT Consultant
Mount Sinai Launches Center for Artificial Intelligence and Human Health
The Icahn School of Medicine at Mount Sinai today announced the launch of a new center dedicated to advancing the delivery of health care through research, development, and implementation of innovative artificial intelligence tools and technologies. The Hamilton and Amabel James Center for Artificial Intelligence and Human Health in Manhattan to combine artificial intelligence with data science and genomics in a standalone site. The building will enable researchers to enhance their
Read More
Mount Sinai Appoints Andrew Kasarskis As First-Ever Chief Data Officer
Mount Sinai has appointed Andrew Kasarskis, Ph.D., an internationally recognized expert in biomedical data as the health system’s first-ever Executive Vice President and Chief Data Officer (CDO). In this new role, Dr. Kasarskis will facilitate the accessibility and sharing of clinical, financial, and administrative data, and open application development, all in support of better patient care, decision-making, and healthcare innovation.
Accelerating Data-Driven Discovery and Patient
Read More
FDA Grants Breakthrough Designation to RenalytixAI for AI-Enabled Diagnostic for Kidney Disease
RenalytixAI, a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, today announced that it has been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA), for its lead diagnostic, KidneyIntelX™. This is the first such designation for an AI-enabled diagnostic for kidney disease publicly announced by any company.FDA Breakthrough Devices Program OverviewThe FDA’s Breakthrough Devices Program is a voluntary program for certain
Read More
Roundtrip Nabs $5.1M to Expand Digital Transportation Marketplace for Providers & Patients
Roundtrip, a Philadelphia, PA-based digital transportation marketplace for better health outcomes announced it has raised $5.14M in Series A funding led by Motley Fool Ventures, with participation from a multi-billion dollar international healthcare software and medical device company, Ben Franklin Technology Partners of Southeastern Pennsylvania and Johns Hopkins University.Digital Transportation MarketplaceEvery day, 10,000 patients miss or delay care due to a transportation barrier. Learn
Read More
March 2019 News, Merger & Acquisition, IPO, Public Company Performance Summary
A brief summary of noteworthy news, health IT M&A activity, IPOs, and public company performance during the month of March.
Noteworthy News
Amazon, JP Morgan, Berkshire Names New Joint Venture Haven
Amazon, J.P. Morgan, and Berkshire Hathaway name joint venture Haven. In January 2018, the three founding companies announced plans to create this independent organization, now called Haven, which is free from profit-making incentives and constraints. Haven’s focus is the 1.2 million
Read More
Mount Sinai Launches Institute for Digital Health to Improve Health Outcomes
The Mount Sinai Health System (MSHS) and the Hasso Plattner Institute (HPI) are teaming up to launch the Hasso Plattner Institute for Digital Health at Mount Sinai with the goal to develop digital health products with real-time predictive and preventive capabilities that empower patients and health care providers and improve health and health outcomes. Together, the new institute brings together industry leaders with combined expertise in health care delivery, health sciences, biomedical and
Read More
Study: Artificial Intelligence May Fall Short for Data Analysis Across Multiple Health Systems
A study reveals artificial intelligence must be carefully tested across multiple environments before being put into clinical practice.Artificial intelligence (AI) tools trained to detect pneumonia on chest X-rays suffered significant decreases in performance when tested on data from outside health systems, according to a new study conducted at the Icahn School of Medicine at Mount Sinai and published in a special issue of PLOS Medicine on machine learning and healthcare. These findings
Read More
Mount Sinai Opens Center for Biomedical Blockchain Research to Develop Healthcare Blockchain Apps
First venture launched by an academic medical center to use blockchain technology to solve healthcare and medical science problems. The Icahn School of Medicine at Mount Sinai and the Institute for Next Generation Healthcare has announced the official opening of the Center for Biomedical Blockchain Research. The center is the first of its kind at any academic medical center to utilize blockchain technology, a distributed, decentralized secure database system originally developed for Bitcoin, to
Read More
Mount Sinai Taps Joel Dudley, PhD to Create Precision Health Enterprise
Joel Dudley, PhD, an internationally recognized investigator in translational bioinformatics and precision medicine, has been named Executive Vice President for Precision Health for the Mount Sinai Health System. In this new role, he will create a Precision Health Enterprise by linking pioneering research conducted in the Icahn School of Medicine at Mount Sinai (ISMMS) with implementation strategies developed in collaboration with leadership and staff throughout the Health System.Precision
Read More
